Targeted RNA interference for hepatic fibrosis (Q37590368)

21 August 2017

1 reference

title

Targeted RNA interference for hepatic fibrosis (English)

1 reference

21 August 2017

1 reference

Ping-Fang Hu

1

1 reference

21 August 2017

Wei-Fen Xie

series ordinal

2

1 reference

21 August 2017

language of work or name

English

0 references

publication date

1 October 2009

1 reference

Expert Opinion on Biological Therapy

21 August 2017

1 reference

21 August 2017

9

1 reference

21 August 2017

10

1 reference

21 August 2017

1305-1312

1 reference

Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury

21 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14712590903213677

Mechanisms of hepatic fibrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903213677

Is liver fibrosis reversible?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903213677

Hepatic fibrosis -- overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903213677

Targeted treatments for cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903213677

Therapeutic potential of RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903213677

Approaches for the sequence-specific knockdown of mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903213677

RNAi therapeutics: principles, prospects and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903213677

Unlocking the potential of the human genome with RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903213677

RNA interference targeting the platelet-derived growth factor receptor beta subunit ameliorates experimental hepatic fibrosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903213677

siRNA-mediated knockdown of connective tissue growth factor prevents N-nitrosodimethylamine-induced hepatic fibrosis in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903213677

Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903213677

Modified synthetic siRNA targeting tissue inhibitor of metalloproteinase-2 inhibits hepatic fibrogenesis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903213677

Targeted delivery of siRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903213677

Targeted delivery systems of small interfering RNA by systemic administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903213677

Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903213677

A novel siRNA-lipoplex technology for RNA interference in the mouse vascular endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903213677

Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903213677

Sustained expression of naked plasmid DNA encoding hepatocyte growth factor in mice promotes liver and overall body growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903213677

In vivo transfection of C/EBP-alpha gene could ameliorate CCL(4)-induced hepatic fibrosis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903213677

Caspase 8 small interfering RNA prevents acute liver failure in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903213677

Nonviral delivery of synthetic siRNAs in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903213677

In vivo gene transfer of endothelial nitric oxide synthase decreases portal pressure in anaesthetised carbon tetrachloride cirrhotic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903213677

Gene transfer of the neuronal NO synthase isoform to cirrhotic rat liver ameliorates portal hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903213677

Hepatocyte-targeted gene transfer by combination of vascularly delivered plasmid DNA and in vivo electroporation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903213677

Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903213677

Transgenic expression of cyclooxygenase-2 in hepatocytes accelerates endotoxin-induced acute liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903213677

Liver-specific ablation of integrin-linked kinase in mice results in abnormal histology, enhanced cell proliferation, and hepatomegaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903213677

Inhibition of rat hepatocellular carcinoma tumor growth after multiple infusions of recombinant Ad.AFPtk followed by ganciclovir treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903213677

Alpha-fetoprotein promoter-targeted sodium iodide symporter gene therapy of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903213677

In vivo targeted gene delivery by cationic nanoparticles for treatment of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903213677

Liver target delivery of small interfering RNA to the HCV gene by lactosylated cationic liposome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903213677

Enhanced hepatocyte-selective in vivo gene expression by stabilized galactosylated liposome/plasmid DNA complex using sodium chloride for complex formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903213677

Gene therapy for liver diseases: recent strategies for treatment of viral hepatitis and liver malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903213677

Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903213677

Systemic and specific delivery of small interfering RNAs to the liver mediated by apolipoprotein A-I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903213677

Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903213677

Hepatic stellate cells as a target for the treatment of liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903213677

Albumin modified with mannose 6-phosphate: A potential carrier for selective delivery of antifibrotic drugs to rat and human hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903213677

Mannose-6-phosphate/insulin-Like growth factor-II receptors may represent a target for the selective delivery of mycophenolic acid to fibrogenic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903213677

The antiproliferative drug doxorubicin inhibits liver fibrosis in bile duct-ligated rats and can be selectively delivered to hepatic stellate cells in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903213677

Local inhibition of liver fibrosis by specific delivery of a platelet-derived growth factor kinase inhibitor to hepatic stellate cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903213677

Synaptophysin: A novel marker for human and rat hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903213677

A dual reporter gene transgenic mouse demonstrates heterogeneity in hepatic fibrogenic cell populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903213677

Generation of a monoclonal human single chain antibody fragment to hepatic stellate cells--a potential mechanism for targeting liver anti-fibrotic therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903213677

Mechanism of action of the antifibrogenic compound gliotoxin in rat liver cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903213677

Antibody-targeted myofibroblast apoptosis reduces fibrosis during sustained liver injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903213677

CSRP2, TIMP-1, and SM22alpha promoter fragments direct hepatic stellate cell-specific transgene expression in vitro, but not in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903213677

Cell type-specific intervention of transforming growth factor beta/Smad signaling suppresses collagen gene expression and hepatic fibrosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903213677

Targeted and regulable expression of transgenes in hepatic stellate cells and myofibroblasts in culture and in vivo using an adenoviral Cre/loxP system to antagonise hepatic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903213677

Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903213677

Extra-neural glial fibrillary acidic protein (GFAP) immunoreactivity in perisinusoidal stellate cells of rat liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903213677

Targeted inhibition of platelet-derived growth factor receptor-beta subunit in hepatic stellate cells ameliorates hepatic fibrosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903213677

Treatment of experimental hepatic fibrosis by combinational delivery of urokinase-type plasminogen activator and hepatocyte growth factor genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903213677

Gene therapy progress and prospects: adenoviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903213677

Superoxide dismutase gene transfer reduces portal pressure in CCl4 cirrhotic rats with portal hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903213677

Hepatic stellate cells secrete angiopoietin 1 that induces angiogenesis in liver fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903213677

Adenovirus-mediated inhibition of SPARC attenuates liver fibrosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903213677

Assessment of efficiency and safety of adenovirus mediated gene transfer into normal and damaged murine livers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903213677

Effect of adenovirus-mediated RNA interference on endogenous microRNAs in a mouse model of multidrug resistance protein 2 gene silencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903213677

Adenovirus-mediated transfer of siRNA against PAI-1 mRNA ameliorates hepatic fibrosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903213677

Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903213677

siRNAs: applications in functional genomics and potential as therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903213677

10.1517/14712590903213677

21 January 2018

Identifiers

DOI

1 reference

release_xrnwgixegfcm5ffvrqwpibrjfe

21 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xrnwgixegfcm5ffvrqwpibrjfe

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference